[DISCLOSURE] Huons (243070) announced on June 25 that it has obtained a patent in the US for an ophthalmic composition comprising cyclosporine and trehalose.  

The composition protects tear film and also is anti-inflammatory, and is currently in the third phase of clinical trials in Korea, said the company. 

By Hwang You-mee (glamazon@heraldcorp.com)